Larimar Therapeutics

$0.00 (0.00%) As of 12:30 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LRMR and other ETFs, options, and stocks.

About LRMR

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia.

CEO
Carole S. Ben-Maimon
Employees
31
Headquarters
Bala Cynwyd, Pennsylvania
Founded
2005

LRMR Key Statistics

Market cap
44.45M
Price-Earnings ratio
—
Dividend yield
—
Average volume
85.30K
High today
$2.58
Low today
$2.45
Open price
$2.54
Volume
113.79K
52 Week high
$15.49
52 Week low
$2.40

LRMR Earnings

-$0.92
-$0.61
-$0.31
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.49 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure